Horizon Investments »

Biosante Pharmaceuticals shares owned by Horizon Investments

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Horizon Investments from 13F filings

Historical chart of Horizon Investments investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Horizon Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Horizon Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $724k 9.4k 76.90
2025-09-30 $546k 6.0k 91.60

More positions owned by Horizon Investments

Spdr S&p 500 Etf (SPY)
SPDR DJ Wilshire Large Cap Growth (SPYG)
Ishares Tr core msci intl (IDEV)
SPDR DJ Wilshire Large Cap Value (SPYV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
SPDR S&P World ex-US (SPDW)
SPDR S&P Emerging Markets (SPEM)
Spdr Ser Tr 1 3 hgh yield (BIL)
SPDR Barclays Capital Aggregate Bo (SPAB)
Listed Fd Tr (MAGS)
Microsoft Corporation (MSFT)
Invesco S&p 500 Equal Weight Etf (RSP)
Alphabet Inc Class A cs (GOOGL)
Ishares Tr usa min vo (USMV)

View all positions for Horizon Investments

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
GoldenTree Asset Management
Deep Track Capital
Millennium Management
Arrowstreet Capital, Limited Partnership
Caption Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Nuveen
Vanguard Portfolio Management

View all funds holding Biosante Pharmaceuticals